10 Scientists Who made the Tick Vaccine

Dr Margaret Saimo-Kahwa, the lead developer of the vaccine,  on Tuesday said the development started in 2005 with a seed grant from the Dutch Research Council,  but the government of Uganda through the Presidential Initiative on Science and Technology took interest and continued providing financial support to date. The completed trial of the vaccine indicates that the overall efficacy of the serum in stopping tick infestation is 86 per cent for brown ear tick that transmits East Coast Fever (ECF)... ECF is one of the deadly tick-borne diseases which is a huge economic threat to farmers with herds of exotic breeds,  cross-breeds and increasingly on local breeds raised in a tick-free environment.

Dr Margaret Saimo-Kahwa, the lead developer of the vaccine,  on Tuesday said the development started in 2005 with a seed grant from the Dutch Research Council,  but the government of Uganda through the Presidential Initiative on Science and Technology took interest and continued providing financial support to date. The completed trial of the vaccine indicates that the overall efficacy of the serum in stopping tick infestation is 86 per cent for brown ear tick that transmits East Coast Fever (ECF)...
ECF is one of the deadly tick-borne diseases which is a huge economic threat to farmers with herds of exotic breeds,  cross-breeds and increasingly on local breeds raised in a tick-free environment. Dr Margaret Saimo-Kahwa, the lead developer of the vaccine,  on Tuesday said the development started in 2005 with a seed grant from the Dutch Research Council,  but the government of Uganda through the Presidential Initiative on Science and Technology took interest and continued providing financial support to date. The completed trial of the vaccine indicates that the overall efficacy of the serum in stopping tick infestation is 86 per cent for brown ear tick that transmits East Coast Fever (ECF)...
ECF is one of the deadly tick-borne diseases which is a huge economic threat to farmers with herds of exotic breeds,  cross-breeds and increasingly on local breeds raised in a tick-free environment. Dr Margaret Saimo-Kahwa, the lead developer of the vaccine,  on Tuesday said the development started in 2005 with a seed grant from the Dutch Research Council,  but the government of Uganda through the Presidential Initiative on Science and Technology took interest and continued providing financial support to date. The completed trial of the vaccine indicates that the overall efficacy of the serum in stopping tick infestation is 86 per cent for brown ear tick that transmits East Coast Fever (ECF)...
ECF is one of the deadly tick-borne diseases which is a huge economic threat to farmers with herds of exotic breeds,  cross-breeds and increasingly on local breeds raised in a tick-free environment. Dr Margaret Saimo-Kahwa, the lead developer of the vaccine,  on Tuesday said the development started in 2005 with a seed grant from the Dutch Research Council,  but the government of Uganda through the Presidential Initiative on Science and Technology took interest and continued providing financial support to date. The completed trial of the vaccine indicates that the overall efficacy of the serum in stopping tick infestation is 86 per cent for brown ear tick that transmits East Coast Fever (ECF)...
ECF is one of the deadly tick-borne diseases which is a huge economic threat to farmers with herds of exotic breeds,  cross-breeds and increasingly on local breeds raised in a tick-free environment. Dr Margaret Saimo-Kahwa, the lead developer of the vaccine,  on Tuesday said the development started in 2005 with a seed grant from the Dutch Research Council,  but the government of Uganda through the Presidential Initiative on Science and Technology took interest and continued providing financial support to date. The completed trial of the vaccine indicates that the overall efficacy of the serum in stopping tick infestation is 86 per cent for brown ear tick that transmits East Coast Fever (ECF)...
ECF is one of the deadly tick-borne diseases which is a huge economic threat to farmers with herds of exotic breeds,  cross-breeds and increasingly on local breeds raised in a tick-free environment. Dr Margaret Saimo-Kahwa, the lead developer of the vaccine,  on Tuesday said the development started in 2005 with a seed grant from the Dutch Research Council,  but the government of Uganda through the Presidential Initiative on Science and Technology took interest and continued providing financial support to date. The completed trial of the vaccine indicates that the overall efficacy of the serum in stopping tick infestation is 86 per cent for brown ear tick that transmits East Coast Fever (ECF)...
ECF is one of the deadly tick-borne diseases which is a huge economic threat to farmers with herds of exotic breeds,  cross-breeds and increasingly on local breeds raised in a tick-free environment. Dr Margaret Saimo-Kahwa, the lead developer of the vaccine,  on Tuesday said the development started in 2005 with a seed grant from the Dutch Research Council,  but the government of Uganda through the Presidential Initiative on Science and Technology took interest and continued providing financial support to date. The completed trial of the vaccine indicates that the overall efficacy of the serum in stopping tick infestation is 86 per cent for brown ear tick that transmits East Coast Fever (ECF)...
ECF is one of the deadly tick-borne diseases which is a huge economic threat to farmers with herds of exotic breeds,  cross-breeds and increasingly on local breeds raised in a tick-free environment. Dr Margaret Saimo-Kahwa, the lead developer of the vaccine,  on Tuesday said the development started in 2005 with a seed grant from the Dutch Research Council,  but the government of Uganda through the Presidential Initiative on Science and Technology took interest and continued providing financial support to date. The completed trial of the vaccine indicates that the overall efficacy of the serum in stopping tick infestation is 86 per cent for brown ear tick that transmits East Coast Fever (ECF)...
ECF is one of the deadly tick-borne diseases which is a huge economic threat to farmers with herds of exotic breeds,  cross-breeds and increasingly on local breeds raised in a tick-free environment. Dr Margaret Saimo-Kahwa, the lead developer of the vaccine,  on Tuesday said the development started in 2005 with a seed grant from the Dutch Research Council,  but the government of Uganda through the Presidential Initiative on Science and Technology took interest and continued providing financial support to date. The completed trial of the vaccine indicates that the overall efficacy of the serum in stopping tick infestation is 86 per cent for brown ear tick that transmits East Coast Fever (ECF)...
ECF is one of the deadly tick-borne diseases which is a huge economic threat to farmers with herds of exotic breeds,  cross-breeds and increasingly on local breeds raised in a tick-free environment. Dr Margaret Saimo-Kahwa, the lead developer of the vaccine,  on Tuesday said the development started in 2005 with a seed grant from the Dutch Research Council,  but the government of Uganda through the Presidential Initiative on Science and Technology took interest and continued providing financial support to date. The completed trial of the vaccine indicates that the overall efficacy of the serum in stopping tick infestation is 86 per cent for brown ear tick that transmits East Coast Fever (ECF)...
ECF is one of the deadly tick-borne diseases which is a huge economic threat to farmers with herds of exotic breeds,  cross-breeds and increasingly on local breeds raised in a tick-free environment. Dr Margaret Saimo-Kahwa, the lead developer of the vaccine,  on Tuesday said the development started in 2005 with a seed grant from the Dutch Research Council,  but the government of Uganda through the Presidential Initiative on Science and Technology took interest and continued providing financial support to date. The completed trial of the vaccine indicates that the overall efficacy of the serum in stopping tick infestation is 86 per cent for brown ear tick that transmits East Coast Fever (ECF)...
ECF is one of the deadly tick-borne diseases which is a huge economic threat to farmers with herds of exotic breeds,  cross-breeds and increasingly on local breeds raised in a tick-free environment. Dr Margaret Saimo-Kahwa, the lead developer of the vaccine,  on Tuesday said the development started in 2005 with a seed grant from the Dutch Research Council,  but the government of Uganda through the Presidential Initiative on Science and Technology took interest and continued providing financial support to date. The completed trial of the vaccine indicates that the overall efficacy of the serum in stopping tick infestation is 86 per cent for brown ear tick that transmits East Coast Fever (ECF)...
ECF is one of the deadly tick-borne diseases which is a huge economic threat to farmers with herds of exotic breeds,  cross-breeds and increasingly on local breeds raised in a tick-free environment. Dr Margaret Saimo-Kahwa, the lead developer of the vaccine,  on Tuesday said the development started in 2005 with a seed grant from the Dutch Research Council,  but the government of Uganda through the Presidential Initiative on Science and Technology took interest and continued providing financial support to date. The completed trial of the vaccine indicates that the overall efficacy of the serum in stopping tick infestation is 86 per cent for brown ear tick that transmits East Coast Fever (ECF)...
ECF is one of the deadly tick-borne diseases which is a huge economic threat to farmers with herds of exotic breeds,  cross-breeds and increasingly on local breeds raised in a tick-free environment. Dr Margaret Saimo-Kahwa, the lead developer of the vaccine,  on Tuesday said the development started in 2005 with a seed grant from the Dutch Research Council,  but the government of Uganda through the Presidential Initiative on Science and Technology took interest and continued providing financial support to date. The completed trial of the vaccine indicates that the overall efficacy of the serum in stopping tick infestation is 86 per cent for brown ear tick that transmits East Coast Fever (ECF)...
ECF is one of the deadly tick-borne diseases which is a huge economic threat to farmers with herds of exotic breeds,  cross-breeds and increasingly on local breeds raised in a tick-free environment. Dr Margaret Saimo-Kahwa, the lead developer of the vaccine,  on Tuesday said the development started in 2005 with a seed grant from the Dutch Research Council,  but the government of Uganda through the Presidential Initiative on Science and Technology took interest and continued providing financial support to date. The completed trial of the vaccine indicates that the overall efficacy of the serum in stopping tick infestation is 86 per cent for brown ear tick that transmits East Coast Fever (ECF)...
ECF is one of the deadly tick-borne diseases which is a huge economic threat to farmers with herds of exotic breeds,  cross-breeds and increasingly on local breeds raised in a tick-free environment. Dr Margaret Saimo-Kahwa, the lead developer of the vaccine,  on Tuesday said the development started in 2005 with a seed grant from the Dutch Research Council,  but the government of Uganda through the Presidential Initiative on Science and Technology took interest and continued providing financial support to date. The completed trial of the vaccine indicates that the overall efficacy of the serum in stopping tick infestation is 86 per cent for brown ear tick that transmits East Coast Fever (ECF)...
ECF is one of the deadly tick-borne diseases which is a huge economic threat to farmers with herds of exotic breeds,  cross-breeds and increasingly on local breeds raised in a tick-free environment. Dr Margaret Saimo-Kahwa, the lead developer of the vaccine,  on Tuesday said the development started in 2005 with a seed grant from the Dutch Research Council,  but the government of Uganda through the Presidential Initiative on Science and Technology took interest and continued providing financial support to date. The completed trial of the vaccine indicates that the overall efficacy of the serum in stopping tick infestation is 86 per cent for brown ear tick that transmits East Coast Fever (ECF)...
ECF is one of the deadly tick-borne diseases which is a huge economic threat to farmers with herds of exotic breeds,  cross-breeds and increasingly on local breeds raised in a tick-free environment. Dr Margaret Saimo-Kahwa, the lead developer of the vaccine,  on Tuesday said the development started in 2005 with a seed grant from the Dutch Research Council,  but the government of Uganda through the Presidential Initiative on Science and Technology took interest and continued providing financial support to date. The completed trial of the vaccine indicates that the overall efficacy of the serum in stopping tick infestation is 86 per cent for brown ear tick that transmits East Coast Fever (ECF)...
ECF is one of the deadly tick-borne diseases which is a huge economic threat to farmers with herds of exotic breeds,  cross-breeds and increasingly on local breeds raised in a tick-free environment. Dr Margaret Saimo-Kahwa, the lead developer of the vaccine,  on Tuesday said the development started in 2005 with a seed grant from the Dutch Research Council,  but the government of Uganda through the Presidential Initiative on Science and Technology took interest and continued providing financial support to date. The completed trial of the vaccine indicates that the overall efficacy of the serum in stopping tick infestation is 86 per cent for brown ear tick that transmits East Coast Fever (ECF)...
ECF is one of the deadly tick-borne diseases which is a huge economic threat to farmers with herds of exotic breeds,  cross-breeds and increasingly on local breeds raised in a tick-free environment. Dr Margaret Saimo-Kahwa, the lead developer of the vaccine,  on Tuesday said the development started in 2005 with a seed grant from the Dutch Research Council,  but the government of Uganda through the Presidential Initiative on Science and Technology took interest and continued providing financial support to date. The completed trial of the vaccine indicates that the overall efficacy of the serum in stopping tick infestation is 86 per cent for brown ear tick that transmits East Coast Fever (ECF)...
ECF is one of the deadly tick-borne diseases which is a huge economic threat to farmers with herds of exotic breeds,  cross-breeds and increasingly on local breeds raised in a tick-free environment. Dr Margaret Saimo-Kahwa, the lead developer of the vaccine,  on Tuesday said the development started in 2005 with a seed grant from the Dutch Research Council,  but the government of Uganda through the Presidential Initiative on Science and Technology took interest and continued providing financial support to date. The completed trial of the vaccine indicates that the overall efficacy of the serum in stopping tick infestation is 86 per cent for brown ear tick that transmits East Coast Fever (ECF)...
ECF is one of the deadly tick-borne diseases which is a huge economic threat to farmers with herds of exotic breeds,  cross-breeds and increasingly on local breeds raised in a tick-free environment. Dr Margaret Saimo-Kahwa, the lead developer of the vaccine,  on Tuesday said the development started in 2005 with a seed grant from the Dutch Research Council,  but the government of Uganda through the Presidential Initiative on Science and Technology took interest and continued providing financial support to date. The completed trial of the vaccine indicates that the overall efficacy of the serum in stopping tick infestation is 86 per cent for brown ear tick that transmits East Coast Fever (ECF)...
ECF is one of the deadly tick-borne diseases which is a huge economic threat to farmers with herds of exotic breeds,  cross-breeds and increasingly on local breeds raised in a tick-free environment. Dr Margaret Saimo-Kahwa, the lead developer of the vaccine,  on Tuesday said the development started in 2005 with a seed grant from the Dutch Research Council,  but the government of Uganda through the Presidential Initiative on Science and Technology took interest and continued providing financial support to date. The completed trial of the vaccine indicates that the overall efficacy of the serum in stopping tick infestation is 86 per cent for brown ear tick that transmits East Coast Fever (ECF)...
ECF is one of the deadly tick-borne diseases which is a huge economic threat to farmers with herds of exotic breeds,  cross-breeds and increasingly on local breeds raised in a tick-free environment.